InvestorWire NewsRoom


Articles Category: Biotechnology
Wednesday Mar 03, 2021 - 12:26 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Reimagines Technology to Create Better Cancer Outcomes

Archaic technology contributes to dismal recurrence rate in bladder cancerImagin Medical revolutionizes the way surgeons can visualize cancer to better identify, and remove during surgeryThere is potential to extend this technology to virtually other endoscopic procedures The battle against cancer is too often set back by crushing blows of recurrence. The disease is insidious. If every single malignant cell of a tumor is not completely…

Continue Reading

Tuesday Mar 02, 2021 - 2:56 pm

United Medical Equipment Business Solutions Network Inc. Stands to Benefit as Health Officials Call for More at Home Testing

Testing is more important than ever, medical experts claim, urging government to speed up widespread testingTens of millions of rapid, at-home tests may be needed every dayUME offers rapid testing kits to help end the pandemic, ready to seize the opportunity The U.S. government has announced plans to roll out more than 60 million home test kits to stop the COVID-19 virus from spreading (…

Continue Reading

Tuesday Mar 02, 2021 - 2:12 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Optimistic About Upcoming Berubicin Trials After IND Approval

Berubicin is CNS Pharmaceuticals’ lead product candidate for treatment of Glioblastoma Multiforme, and has the potential to be the first anthracycline to cross the blood-brain barrier based on limited results from a Phase 1 trialThe market for GBM treatment is estimated to reach $3.3 billion in 2024, growing at a CAGR of 17.4%CNS, in collaboration with sublicensee partner WPD Pharmaceuticals, is currently planning three Berubicin…

Continue Reading

Friday Feb 26, 2021 - 1:49 pm

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Releases Record-Breaking Gross Revenue for January 2021

Company reports record gross revenues of C$1,089,502 last month“It is truly encouraging to achieve yet another incredible revenue milestone and to start the new year with such vigor and success,” states CEORecord revenue comes during one of slowest e-commerce periods of year, highlighting impact the company has in the plant-based marketplace PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) saw record gross revenues last month (…

Continue Reading

Friday Feb 26, 2021 - 1:36 pm

Predictive Oncology Inc. (NASDAQ: POAI) Receives ‘Buy’ Rating from Litchfield Hills Research in First Analyst Coverage Report

Calling POAI undervalued, Litchfield initiates coverage of Predictive Oncology with Buy rating, $3 price targetThe drug industry is changing as tools and technology to tailor drugs emerge, regulatory bodies focus on patients’ experiences, perspectives, needsLitchfield report notes several POAI strengths under “Investment Thesis” section A growing number of companies and health providers alike are paying attention to what the FDA is calling patient-focused drug development…

Continue Reading

Friday Feb 26, 2021 - 12:15 pm

Better Cancer Outcomes Possible with Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology

Imagin Medical Inc.’s patented i/Blue System revolutionizes the way surgeons are able to visualize the bladder and identify cancers during surgeryThe breakthrough technology of Imagin Medical’s i/Blue Imaging System rectifies the limitations of both white and blue light cystoscopiesBladder cystoscopies first target - multiple other endoscopic procedures planned Science and technology have continued to make striking advancements in cancer therapeutics and treatment protocols, improving upon…

Continue Reading

Thursday Feb 25, 2021 - 12:57 pm

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) Reports Its Plant-Based Biopesticide Has Positive Impact on Soil Health

Studies confirm natural active ingredient, which is in MustGrow’s biopesticide, has a positive impact on soil healthSoil micro-organisms play crucial role in soil fertility, plant healthMustGrow's safe, effective natural biopesticide is plant based, derived from the mustard seed's natural defense mechanism MustGrow Biologics (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) has released study findings that confirm that the active ingredient in its mustard plant-based technology actually has…

Continue Reading

Wednesday Feb 24, 2021 - 3:18 pm

United Medical Equipment Business Solutions Network Inc. Providing Solutions to Combat the Spread of COVID-19

UME is trusted supplier of FDA-approved antibody, antigen test kitsUnited moved quickly to address growing needs created by COVID-19Company dedicated to providing guidance to aging population, their families and medical staff supporting them United Medical Equipment Business Solutions Network is a company focused on the needs of aging patients and veteran communities as well as those impacted by the COVID-19 pandemic. United is a trusted…

Continue Reading

Wednesday Feb 24, 2021 - 1:33 pm

PlantX Life Inc.’s (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Collaboration with Farm Cup Coffee Designed to Boost Brand, Reach Customers and Inspire Lifestyles

PlantX to display and sell its indoor plants at Farm Cup Coffee’s highly attractive West Hollywood locationThe careful partnership aligns perfectly with PlantX’s commitment to supporting healthy lifestyles and community empowermentPlantX opens wide the potential of indoor plants, making it both easy and appealing to discover what the world of plants can provide As the digital face of the plant-based community, PlantX Life (CSE: VEGA)…

Continue Reading

Wednesday Feb 24, 2021 - 1:18 pm

Predictive Oncology Inc. (NASDAQ: POAI) Subsidiaries Ink Significant Contract, Announce Sale of Media to Top Medical Centers

POAI subsidiary inks contract with significant pharmaceutical companyTumorGenesis announces sale of media to research medical centers in New York City, BostonPotential market for 3D cancer cell culture media expected to reach $3.2 billion sales worldwide by 2027 Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that one of its wholly owned subsidiaries, Soluble Biotech,…

Continue Reading

Monday Feb 22, 2021 - 12:44 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Advances Rapid COVID Test System, Expands Psychedelic Medicine Programs

Life sciences industry accelerator XPhyto Therapeutics Corp. has developed a timeline for the approval and rollout of a rapid, portable COVID-19 test it expects to become available by April in EuropeXPhyto’s Covid-ID Lab system is designed to help industries economically devastated by the pandemic to form strategies based on quick and accurate testing, particularly the travel industryThe company intends to use its test tech partnership…

Continue Reading

Monday Feb 22, 2021 - 11:57 am

Convertible Note Progress Brings Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Closer to Commercialization of New Surgical Tech

Imagin Medical Inc. announced that it has now raised $2.165 million of the recent its convertible note offeringThe closing of the latest funding tranche will support the company’s progress toward the commercialization of its revolutionary bladder cancer visualization technology once final FDA approval is grantedWith better viewing options, the technology is designed to make it easier for surgeons to detect the full parameters of bladder…

Continue Reading

Monday Feb 22, 2021 - 10:30 am

VistaGen Therapeutics Inc. (NASDAQ: VTGN) Committed to Developing New Generation Alternatives to Current Standard of Care for Anxiety Disorders

American Psychiatric Association poll reveals 62% of respondents have anxiety about COVID-19Recent FDA Drug Safety Communication requires updated Boxed Warning for benzodiazepines commonly used to treat anxiety disordersVTGN is committed to developing and commercializing PH94B, a first-in-class pherine nasal spray with potential to go beyond the current standard of care for acute treatment of social anxiety disorder and other anxiety-related disorders Anxiety induced by the…

Continue Reading

Friday Feb 19, 2021 - 11:35 am

Ryah Group Inc. Making Digital Transformation in the Lab a Reality

Company has completed steps necessary to achieve, sustain competitive advantage in move towards remote-health solutions and trialsRYAH technology optimizes patient feedback so medical trials, studies can move into remote solution zonesRecently developed an integrated, customized mobile application to support a major clinical study in the United KingdomRYAH created cloud of stored data to help with R&D of future medical treatments RYAH Group, a leading digital…

Continue Reading

Thursday Feb 18, 2021 - 9:41 am

Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Improving the Odds in Fighting Bladder Cancers

Imagin Medical Inc. is a surgical imaging company helping to advance the use of blue light cystoscopy (“BLC”) in battling bladder cancer and reducing costs associated with these proceduresBladder cancer is the sixth most prevalent cancer in the United States, and the third most common in men, yet the most expensive to treat While early-stage cancer intervention involves illuminating the bladder with white light –…

Continue Reading

Thursday Feb 18, 2021 - 9:21 am

VistaGen Therapeutics Inc. (NASDAQ: VTGN) Committed to Developing New Generation of Medicines with Potential to Treat Rising Mental Health Challenges from Depression

Mental health experts note growing concern over impact of COVID-19 on nation’s mental healthCompounding stress could have serious health, social consequencesVTGN offers new hope to those dealing with depression disorders A new survey from the American Psychological Association (“APA”) shines a spotlight on the growing concern about the impact of the global pandemic on the nation’s mental health ( These rising numbers, as well as the…

Continue Reading

Tuesday Feb 16, 2021 - 3:26 pm

United Medical Equipment Business Solutions Network Inc. Stands Ready to Address Swelling Market Need

Frequent, COVID-19 rapid tests could spur end of pandemic, make stay-at-home orders possibleCountries turning to faster, more affordable tests to curb virus spread, enable economic recoveryUnited Medical poised to capitalize on surging demand for rapid testing Frequent rapid testing could curb COVID-19 within weeks, a recent study published by the University of Colorado Boulder and Harvard University shows ( Factors such as test turnaround-time and…

Continue Reading

Tuesday Feb 16, 2021 - 2:29 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Outlines 2021 Business Strategies for COVID-19 PCR Testing and Psychedelic Treatments

XPhyto Therapeutics Corp. plans to commercialize its rapid and portable PCR Kit this year to provide point-of-care diagnosticsThe company is confident about the successful validation of the PCR kit for the European commercial (CE-IVD) approval in Q1 2021Hugh Rogers, CEO and Director of XPhyto, revealed in the latest news release that the company will make investments and development of psychedelic treatments XPhyto Therapeutics Corp. (CSE: XPHY)…

Continue Reading

Tuesday Feb 16, 2021 - 11:38 am

MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) Plant-Based Biopesticide Achieves 100% Control of Root-Rot Disease in Recent Studies

Most recent tests show MustGrow’s patented biopesticide achieved 100% control over Aphanomyces within 24 hoursPlant-based biopesticide uses natural defense mechanism found in mustard seed to control diseases, pests and weedsMustGrow hoping to provide valuable crop-protection tool for pulse-crop farmers MustGrow Biologics (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) has announced that its plant-based biopesticide has achieved 100% control of root-rot disease in a recent round of…

Continue Reading

Friday Feb 12, 2021 - 3:22 pm

CNS Pharmaceuticals (NASDAQ: CNSP) Celebrates IND Status, Prepares to Launch Brain Cancer Drug Trials

Brain cancer drug developer CNS Pharmaceuticals is celebrating recent news that the U.S. Food and Drug Administration (“FDA”) granted investigational new drug (“IND”) status to CNS Pharmaceuticals’ leading candidate for fighting glioblastomasGlioblastomas are a class of aggressive brain cancers with no known cure and a median life expectancy of 14 to 16 months following diagnosisThe FDA’s decision to grant CNSP’s request for IND status clears…

Continue Reading

Friday Feb 12, 2021 - 2:39 pm

Brain Scientific Inc. (BRSF) Establishing New Innovative Norms for Clinicians

Bergen Neurology Consultants utilized BRSF’s devices to improve patient careMinimal training means more staff can administer, monitor the EEG; more appointments can be scheduled Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company focused on developing innovative and proprietary medical devices and software, has created two devices designed to disrupt the EEG market. The NeuroCap(TM) and NeuroEEG(TM) offer cost-effective, disposable substitutes that help improve patient’s access…

Continue Reading

Wednesday Feb 10, 2021 - 2:13 pm

Predictive Oncology Inc. (NASDAQ: POAI) Enters into Definitive Agreements for Direct Offering Totaling Estimated $3 Million

Definitive agreements with institutional, accredited investors call for issuance and sale of more than 3.5 million shares of common stockPOAI currently focused on applying AI to develop personalized medical treatments, novel lab media and improved vaccinesOne of POAI’s highest priorities is building multi-omic predictive models of tumor drug response and outcome Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to…

Continue Reading

Monday Feb 08, 2021 - 2:33 pm

United Medical Equipment Business Solutions Network Inc. Offers Rapid COVID-19 Test Designed to Identify Infection

FDA has authorized 225-plus diagnostic tests for COVID-19 since pandemic beganCareStart(TM) COVID-19 antigen test received FDA authorization in July 2020UME carries CareStart antigen kit, a powerful component of COVID-19 screening process Since the beginning of the COVID-19 pandemic, the U.S. Food and Drug Administration (“FDA”) has authorized more than 225 diagnostic tests for COVID-19 in an effort to provide growing resources to combat the disease.…

Continue Reading

Monday Feb 08, 2021 - 2:25 pm

RYAH Group Inc. Well Positioned as Data Continues to Shape Future of Medical Research

Recent article finds that data remains one of main drivers of medical research in 2021.New technologies employing AI powered by big data provide new solutions for tackling health problems, expand possibilities of clinical researchRYAH combines power of devices combined with data to impact future of medical research to advance treatment of various medical conditions A recent Becker’s Hospital Review article cites 10 emerging trends in…

Continue Reading

Monday Feb 08, 2021 - 12:07 pm

Predictive Oncology Inc. (NASDAQ: POAI) Stands to Benefit from Explosive Growth of Precision Medicine

Precision medicine in oncology allows for clinicians to develop personalized cancer treatment plans using individual characteristics of each patientDoctors use insights drawn from laboratory-grown cancer cells, patients’ DNA to individualize cancer treatmentPredictive Oncology has been forerunner in its field, both through Helomics division’s smart tumor profiling platform as well as TumorGenesis subsidiary, which creates the tools used in ovarian cancer researchTumorGenesis has begun to commercialize…

Continue Reading

Friday Feb 05, 2021 - 1:57 pm

TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) Is ‘One to Watch’

TAAT Lifestyle & Wellness is focused on serving the current smokers’ market, offering its target audience the opportunity to keep the smoking experience that they enjoy with no nicotine and no tobaccoThe company’s proprietary product, TAAT Beyond Tobacco, undergoes a patent-pending refinement processThe product was successfully launched in Ohio during Q4 2020, with nearly one-third of the visitors to the TryTAAT webpage requesting their samples…

Continue Reading

Friday Feb 05, 2021 - 1:42 pm

Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Proprietary System Could Help Reduce Bladder Cancer Recurrence

The current standard for bladder cancer visualization, white light, is over three decades old and used in 95% of the bladder cancer surgeriesThe recurrence rate of bladder cancer is more than 50% due to the inability to see clear margins in the white light surgical standard for visualizationImagin Medical Inc.’s proprietary i/Blue(TM) System changes the way that surgeons visualize bladder cancer with side-by-side imaging of…

Continue Reading

Friday Feb 05, 2021 - 1:31 pm

Brain Scientific Inc. (BRSF) Helps Identify Decision Triggers in Super Bowl Ads and COVID-19 Ads

Using BRSF's EEG products, Marketing Brainology was able to identify the most effective method for dispensing COVID-19 messagingCollected invaluable data for the current pandemic as well as how to navigate the future Brain Scientific (OTCQB: BRSF) is focused on developing innovative and proprietary medical devices and software. As the company works to modernize brain diagnostics through cutting-edge tech, it has also collaborated with Marketing Brainology,…

Continue Reading

Thursday Feb 04, 2021 - 4:24 pm

United Medical Equipment Business Solutions Network Inc. to Thrive as High-Filtration Masks Gain Traction; Doctors Call for National Hi-Fi Mask Initiative

Not all face masks equally effective; high-filter masks proven most powerfulDoctors call for national hi-fi mask initiative to widely distribute masks to each householdUnited Medical offers high-filter masks; positioned to capitalize on broader recognition of hi-fi masks Not all masks are created equals, states a recent Stat article, which underscores the importance of high-filtration (hi-fi) masks. The article, titled "Along with vaccine rollouts, the U.S.…

Continue Reading

Thursday Feb 04, 2021 - 10:05 am

Brain Scientific Inc. (BRSF) Offers Possible Solution for Detecting and Studying Parkinson’s

Parkinsons is diagnosed through skilled observation of specialized neurologistsNeurologist shortage could turn into public emergencyEEGs may hold the key to clearer diagnosis of Parkinson's Every year an estimated 60,000 people in the United States are diagnosed with Parkinson's disease (PD) ( Symptoms develop slowly, often spanning years, and vary from person to person. For a long time, PD has been diagnosed through the skilled observation…

Continue Reading

Tuesday Feb 02, 2021 - 3:08 pm

Brain Scientific Inc. (BRSF) E-Tattoo Will Offer AI Solutions for Neurology

BRSF paving way with next wave of innovation for neurology: e-tattoosAcceptance of telemedicine, AI here to stay following pandemicScientists have learned how to read brain waves using minimally invasive, implantable, four-channel micro EEG to better monitor continuous seizures The COVID-19 pandemic has accelerated several changes to American culture, many of which appear to be here to stay. According to Harvard experts, some of those changes…

Continue Reading

Friday Jan 29, 2021 - 12:13 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Contracts Torrey Hills Capital to Boost Awareness of Its Proprietary Cancer Visualization Technology

Torrey Hills Capital is a leading investor and financial public relations firm that offers extensive expertise in investor relations, corporate communications and other market support operationsThe services provided to Imagin Medical will be overseen by Torrey Hills Founder and Principal Cliff MastricolaImagin believes its proprietary imaging technology, the i/Blue Imaging System(TM), will establish a new standard of care in visualizing cancer during minimally invasive proceduresCompany’s…

Continue Reading

Thursday Jan 28, 2021 - 3:51 pm

United Medical Equipment Business Solutions Network Inc. Breaks Barriers to Medication Adherence

Flaws in the U.S. health-care system revealed during COVID-19 pandemicLack of medication adherence can lead to serious issues, including worsening of disease, possible death and increased costsUnited Medical offers solutions for poor patient-physician communication and inadequate medication knowledge The COVID-19 pandemic has revealed flaws in the U.S. health-care system, including flaws that require patients and caregivers to take a more active and educated role. United…

Continue Reading

Thursday Jan 28, 2021 - 2:14 pm

Predictive Oncology (NASDAQ: POAI) Subsidiary Working to Individualize, Improve Ovarian Cancer Treatment Options

Ovarian cancer is a leading cause of death, causes more death than any other female reproductive system cancerPOAI’s Helomics dedicated to improving clinical decision making for ovarian cancer patientsHelomics has pioneered testing of drugs on patients’ own tumors to help oncologists individualize treatment options According to the American Cancer Society, an estimated 21,750 women received a new diagnosis of ovarian cancer this year, and almost…

Continue Reading

Wednesday Jan 27, 2021 - 3:45 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Discusses Product Pipeline, Clinical Trial Plans, at H.C. Wainwright Bioconnect 2021 Virtual Conference

Company will initiate a Phase II adult trial for Berubicin this year focused on patients with glioblastoma multiformeWPD, a CNS sub-license partner, will be commencing a parallel Phase II adult trial and the first-ever pediatric Berubicin trialAdditional clinical trials are in the pipeline, including one for the company’s newest drug candidate, WP1244, and its effects on central nervous system tumors Biopharmaceutical company CNS Pharmaceuticals (NASDAQ:…

Continue Reading

Tuesday Jan 26, 2021 - 2:45 pm

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Well Placed as Agricultural Biopesticides Market Expected to Grow Rapidly

Research shows that market for agricultural biopesticides expected to grow rapidly at CAGR of 14.7% until 2025MustGrow providing natural plant-based biopesticide solutions for protecting plants from pests and diseases, utilizing the natural defense mechanism of the mustard plantCompany seems well positioned within biopesticides market expected to achieve fastest growth The market for agricultural biopesticides is growing rapidly. The latest Markets and Markets report estimated the…

Continue Reading

Tuesday Jan 26, 2021 - 2:11 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Enters 2021 with Optimism for Its Cancer Imaging Technology

Imagin Medical Inc. successfully weathered the 2020 pandemic-induced economic challenges and transitioned its surgical visualization product, the i/Blue Imaging System(TM) from the development stage to manufacturing  and has  afterImagin’s next stage will be supported by a $3 million convertible note, with the final funding tranche expected to close this quarterThe i/Blue Imaging System combines the advantages of blue light with advanced optic and light sensors…

Continue Reading

Monday Jan 25, 2021 - 1:13 pm

United Medical Equipment Business Solutions Network Inc. Adds CareStart Antigen Test to List of COVID-19 Supplies

UME commited to offering high-quality COVID-19 services, solutions and supplies.To effectively end worldwide pandemic, systematic screening and detection of both clinical and asumptomatic COVID-19 tests is critical.CareStart antigen test features 10-minute processing time, identifies acute infection, helps provide critical answers. Despite approval and rollout of COVID-19 vaccines, experts agree that even as the pandemic dies down in the coming months, SARS-CoV-2, the virus that causes…

Continue Reading

Friday Jan 22, 2021 - 2:18 pm

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Disrupting Global Agricultural Markets

Company shares update of biopesticide product pipelineMGROF committed to combating deadly crop diseases, pests in Colombia and North AmericaMustGrow touts potential additional uses as bioherbicide, sprout suppressor MustGrow Biologics (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops and other markets, recently provided an update of its biopesticide product pipeline ( By extracting natural compounds…

Continue Reading

Friday Jan 15, 2021 - 10:02 am

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Offers Significant Advantages Over Current Standard Of Visualizing Bladder Cancer During Surgery

The number of bladder cancer cases in 2020 is estimated at 81,400, nearly 4.5% of all newly diagnosed cancer cases, and the current bladder cancer research market is projected to grow at a CAGR of 4.03% through 2026White light, the most widely accepted current standard of care for bladder cancer removal, may not be the best option in helping to prevent recurrence, leaving hundreds of…

Continue Reading

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).